Answers are grounded in this paper and cite their sources.
This evidence report on interferon-free therapy for chronic hepatitis C virus infection includes a systematic review of the literature, a cost-effectiveness model, and a budget impact assessment to support a December 2014 public meeting of the California Technology Assessment Forum.
No takes yet. Share an insight, caveat, or question.
Tice et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: